JP2000166599A - 標的核酸の定量分析方法 - Google Patents
標的核酸の定量分析方法Info
- Publication number
- JP2000166599A JP2000166599A JP10353254A JP35325498A JP2000166599A JP 2000166599 A JP2000166599 A JP 2000166599A JP 10353254 A JP10353254 A JP 10353254A JP 35325498 A JP35325498 A JP 35325498A JP 2000166599 A JP2000166599 A JP 2000166599A
- Authority
- JP
- Japan
- Prior art keywords
- primer
- nucleic acid
- molecule
- pcr
- target nucleic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 67
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 65
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 65
- 238000004445 quantitative analysis Methods 0.000 title claims description 6
- 238000000034 method Methods 0.000 claims abstract description 75
- 230000003321 amplification Effects 0.000 claims abstract description 43
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 43
- 239000007788 liquid Substances 0.000 claims abstract description 16
- 238000005259 measurement Methods 0.000 claims description 65
- 238000005311 autocorrelation function Methods 0.000 claims description 12
- 239000012085 test solution Substances 0.000 claims description 12
- 239000007850 fluorescent dye Substances 0.000 claims description 11
- 230000003287 optical effect Effects 0.000 claims description 10
- 238000009396 hybridization Methods 0.000 claims description 9
- 238000002372 labelling Methods 0.000 claims description 9
- 230000008859 change Effects 0.000 claims description 7
- 230000033001 locomotion Effects 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 claims description 5
- -1 Cy3 Chemical compound 0.000 claims description 4
- 239000012472 biological sample Substances 0.000 claims description 3
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 claims description 2
- 230000000295 complement effect Effects 0.000 claims description 2
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 claims description 2
- 230000002123 temporal effect Effects 0.000 claims description 2
- 238000003752 polymerase chain reaction Methods 0.000 abstract description 75
- 238000006243 chemical reaction Methods 0.000 abstract description 35
- 238000000926 separation method Methods 0.000 abstract description 8
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract description 2
- 239000000523 sample Substances 0.000 description 52
- 238000002060 fluorescence correlation spectroscopy Methods 0.000 description 38
- 239000000047 product Substances 0.000 description 26
- 108020004414 DNA Proteins 0.000 description 25
- 238000007846 asymmetric PCR Methods 0.000 description 16
- 238000001514 detection method Methods 0.000 description 15
- 238000009792 diffusion process Methods 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 239000011521 glass Substances 0.000 description 10
- 230000000007 visual effect Effects 0.000 description 10
- 238000011002 quantification Methods 0.000 description 8
- 102000053602 DNA Human genes 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 238000001502 gel electrophoresis Methods 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 238000004364 calculation method Methods 0.000 description 6
- 239000006059 cover glass Substances 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- 108020004682 Single-Stranded DNA Proteins 0.000 description 5
- 239000000975 dye Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000010186 staining Methods 0.000 description 4
- 238000000246 agarose gel electrophoresis Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000005382 thermal cycling Methods 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 230000005653 Brownian motion process Effects 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- QTANTQQOYSUMLC-UHFFFAOYSA-O Ethidium cation Chemical compound C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 QTANTQQOYSUMLC-UHFFFAOYSA-O 0.000 description 2
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 2
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 2
- 241000725303 Human immunodeficiency virus Species 0.000 description 2
- 101710163270 Nuclease Proteins 0.000 description 2
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 238000005537 brownian motion Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000004590 computer program Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 229960005542 ethidium bromide Drugs 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000001506 fluorescence spectroscopy Methods 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 238000001415 gene therapy Methods 0.000 description 2
- 239000005090 green fluorescent protein Substances 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 239000000138 intercalating agent Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 239000002751 oligonucleotide probe Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000004611 spectroscopical analysis Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- VADKRMSMGWJZCF-UHFFFAOYSA-N 2-bromophenol Chemical compound OC1=CC=CC=C1Br VADKRMSMGWJZCF-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- 208000034454 F12-related hereditary angioedema with normal C1Inh Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 238000002944 PCR assay Methods 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 101710137500 T7 RNA polymerase Proteins 0.000 description 1
- ULHRKLSNHXXJLO-UHFFFAOYSA-L Yo-Pro-1 Chemical compound [I-].[I-].C1=CC=C2C(C=C3N(C4=CC=CC=C4O3)C)=CC=[N+](CCC[N+](C)(C)C)C2=C1 ULHRKLSNHXXJLO-UHFFFAOYSA-L 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- WZSUOQDIYKMPMT-UHFFFAOYSA-N argon krypton Chemical compound [Ar].[Kr] WZSUOQDIYKMPMT-UHFFFAOYSA-N 0.000 description 1
- DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- UIZLQMLDSWKZGC-UHFFFAOYSA-N cadmium helium Chemical compound [He].[Cd] UIZLQMLDSWKZGC-UHFFFAOYSA-N 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- VYXSBFYARXAAKO-WTKGSRSZSA-N chembl402140 Chemical compound Cl.C1=2C=C(C)C(NCC)=CC=2OC2=C\C(=N/CC)C(C)=CC2=C1C1=CC=CC=C1C(=O)OCC VYXSBFYARXAAKO-WTKGSRSZSA-N 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 238000011840 criminal investigation Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 238000005315 distribution function Methods 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000000475 fluorescence cross-correlation spectroscopy Methods 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- CPBQJMYROZQQJC-UHFFFAOYSA-N helium neon Chemical compound [He].[Ne] CPBQJMYROZQQJC-UHFFFAOYSA-N 0.000 description 1
- 208000016861 hereditary angioedema type 3 Diseases 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000009830 intercalation Methods 0.000 description 1
- 230000002687 intercalation Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000029052 metamorphosis Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 238000001579 optical reflectometry Methods 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 238000011533 pre-incubation Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000000941 radioactive substance Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000010223 real-time analysis Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- ACOJCCLIDPZYJC-UHFFFAOYSA-M thiazole orange Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1.C1=CC=C2C(C=C3N(C4=CC=CC=C4S3)C)=CC=[N+](C)C2=C1 ACOJCCLIDPZYJC-UHFFFAOYSA-M 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10353254A JP2000166599A (ja) | 1998-12-11 | 1998-12-11 | 標的核酸の定量分析方法 |
| US09/325,189 US7115365B2 (en) | 1998-12-07 | 1999-06-03 | Method of analyzing a target nucleic acid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10353254A JP2000166599A (ja) | 1998-12-11 | 1998-12-11 | 標的核酸の定量分析方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2000166599A true JP2000166599A (ja) | 2000-06-20 |
| JP2000166599A5 JP2000166599A5 (https=) | 2006-02-23 |
Family
ID=18429599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10353254A Pending JP2000166599A (ja) | 1998-12-07 | 1998-12-11 | 標的核酸の定量分析方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2000166599A (https=) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004527742A (ja) * | 2001-03-09 | 2004-09-09 | グノーティス ホールディング ソシエテ アノニム | 蛍光−相関分光法による分析物の測定 |
| EP2895627A4 (en) * | 2012-09-17 | 2016-06-29 | Univ Brandeis | COMBINATION OF DSDNA BINDING DYES AND PROBES FOR CHARACTERIZING SSDNA SEQUENCES |
-
1998
- 1998-12-11 JP JP10353254A patent/JP2000166599A/ja active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004527742A (ja) * | 2001-03-09 | 2004-09-09 | グノーティス ホールディング ソシエテ アノニム | 蛍光−相関分光法による分析物の測定 |
| EP2895627A4 (en) * | 2012-09-17 | 2016-06-29 | Univ Brandeis | COMBINATION OF DSDNA BINDING DYES AND PROBES FOR CHARACTERIZING SSDNA SEQUENCES |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8831887B2 (en) | Absolute PCR quantification | |
| US7115365B2 (en) | Method of analyzing a target nucleic acid | |
| US12258623B2 (en) | Multiomic analysis device and methods of use thereof | |
| Fried et al. | Optical nanopore sensors for quantitative analysis | |
| WO2009098079A1 (en) | Thermo-optical characterisation of nucleic acid molecules | |
| JP2005295877A (ja) | 核酸分析方法、分析装置及び分析用ディスク | |
| Friedrich et al. | Analysis of single nucleic acid molecules in micro-and nano-fluidics | |
| CN107868815A (zh) | 减少由数字聚合酶链式反应中的反应体积偏差引起的定量误差的方法 | |
| US20180135110A1 (en) | Devices and methods to detect biomarkers using oligonucleotides | |
| Shin et al. | Analytical techniques for nucleic acid and protein detection with single-molecule sensitivity | |
| EP1935496A1 (en) | Device and/or method for the detection of amplified nucleotides sequences on micro-arrays | |
| JP4262336B2 (ja) | 標的核酸の定量分析方法 | |
| JP4217318B2 (ja) | 標的核酸の定量分析方法および装置 | |
| US11091803B2 (en) | Nucleic acid quantification method | |
| EP1180549B1 (en) | Method of measuring polymorphism | |
| US6518027B2 (en) | Sample preparation method and a sample preparation apparatus for DNA analysis | |
| US20230287479A1 (en) | Identifying target nucleic acids using immobilized nuclease | |
| CA2424806A1 (en) | Method and device for analysing chemical or biological samples | |
| JP2000166599A (ja) | 標的核酸の定量分析方法 | |
| JP3910000B2 (ja) | １塩基置換検出方法 | |
| WO2015046435A1 (ja) | 反応容器、核酸解析装置、および核酸解析方法 | |
| JP2004187607A (ja) | 核酸増幅産物に関する情報を得る方法 | |
| US20200061617A1 (en) | Devices and methods for nucleic acid identification | |
| EP1946841A1 (en) | Device and/or method for the detection of amplified nucleotides sequences on micro-arrays | |
| JP2001269198A (ja) | 多型遺伝子の型を決定する方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20051207 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20051207 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20051207 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20051207 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080722 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080919 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20081021 |